» Articles » PMID: 22232435

Mesenchymal Stem Cells Induce Functionally Active T-regulatory Lymphocytes in a Paracrine Fashion and Ameliorate Experimental Autoimmune Uveitis

Overview
Specialty Ophthalmology
Date 2012 Jan 11
PMID 22232435
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Mesenchymal stem/progenitor cells (MSCs) have regenerative and immunomodulatory properties, exerted by cell-cell contact and in a paracrine fashion. Part of their immunosuppressive activity has been ascribed to their ability to promote the induction of CD4+CD25+FoxP3+ T lymphocytes with regulatory functions (Treg). Here the authors studied the effect of MSCs on the induction of Treg and on the development of autoimmunity, and they examined the possibility that MSC-mediated Treg induction could be attributed to the secretion of soluble factors.

Methods: The authors induced experimental autoimmune uveitis (EAU) in mice by immunization with the 1-20 peptide of the intraphotoreceptor binding protein. At the same time, some of the animals were treated intraperitoneally with syngeneic MSCs. The authors checked T-cell responses and in vitro Treg conversion by cell proliferation and blocking assays, in cell-cell contact and transwell settings. TGFβ and TGFβ receptor gene expression analyses were performed by real-time PCR.

Results: The authors found that a single intraperitoneal injection of MSCs was able to significantly attenuate EAU and that a significantly higher percentage of adaptive Treg was present in MSC-treated mice than in MSC-untreated animals. In vitro blocking of antigen presentation by major histocompatibility complex class II precluded priming and clonal expansion of antigen-specific Treg, whereas blockade of TGFβ impaired the expression of FoxP3, preventing the conversion of CD4+ T cells into functionally active Treg.

Conclusions: The authors demonstrated that MSCs can inhibit EAU and that their immunomodulatory function is due at least in part to the induction of antigen-specific Treg in a paracrine fashion by secreting TGFβ.

Citing Articles

Regulatory T Cells: Therapeutic Opportunities in Uveitis.

Lee A, Foulsham W Front Ophthalmol (Lausanne). 2024; 2:901144.

PMID: 38983511 PMC: 11182269. DOI: 10.3389/fopht.2022.901144.


Exosomes in asthma: Underappreciated contributors to the pathogenesis and novel therapeutic tools.

Kanannejad Z, Arab S, Soleimanian S, Mazare A, Kheshtchin N Immun Inflamm Dis. 2024; 12(6):e1325.

PMID: 38934401 PMC: 11209551. DOI: 10.1002/iid3.1325.


Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis.

Duan Y, Chen X, Shao H, Li Y, Zhang Z, Li H Stem Cell Res Ther. 2024; 15(1):149.

PMID: 38783393 PMC: 11118760. DOI: 10.1186/s13287-024-03764-7.


Mesenchymal stem cell based therapies for uveitis: a systematic review of preclinical studies.

Kanda P, Gupta A, Dhillon J, Kundapur D, Gottlieb C Eye (Lond). 2024; 38(10):1845-1854.

PMID: 38600361 PMC: 11226430. DOI: 10.1038/s41433-024-03057-6.


Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease.

Doglio M, Crossland R, Alho A, Penack O, Dickinson A, Stary G Front Immunol. 2022; 13:1045168.

PMID: 36466922 PMC: 9714556. DOI: 10.3389/fimmu.2022.1045168.


References
1.
Silver P, Rizzo L, Chan C, Donoso L, Wiggert B, Caspi R . Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype. Invest Ophthalmol Vis Sci. 1995; 36(5):946-54. View

2.
Pennesi G, Mattapallil M, Sun S, Avichezer D, Silver P, Karabekian Z . A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest. 2003; 111(8):1171-80. PMC: 152930. DOI: 10.1172/JCI15155. View

3.
Francois M, Romieu-Mourez R, Stock-Martineau S, Boivin M, Bramson J, Galipeau J . Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties. Blood. 2009; 114(13):2632-8. DOI: 10.1182/blood-2009-02-207795. View

4.
Grajewski R, Silver P, Agarwal R, Su S, Chan C, Liou G . Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J Exp Med. 2006; 203(4):851-6. PMC: 2118294. DOI: 10.1084/jem.20050429. View

5.
Sugita S, Yamada Y, Kaneko S, Horie S, Mochizuki M . Induction of regulatory T cells by infliximab in Behcet's disease. Invest Ophthalmol Vis Sci. 2010; 52(1):476-84. DOI: 10.1167/iovs.10-5916. View